it appears that pfizer is going to take over wyeth for between 65 and 70 billion $us.this could well be the start of alot of consolidation in the pharma industry.acrux with their pipeline of products.evamist/ellavie/animal products/female testosterone/and most importantly male testosterone(market 1 billion dollars and growing at 20%) could be a subject to takeover offer as its price at the moment appears to be very cheap.valuation from brokers range between $1 and $2.60.company is currently valued at 90 million with 30 million in the bank.accordingly all other assets are valued at just 60 million .this does not seem alot for the pipeline
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.957M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 187500 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 358041 | 1 |
View Market Depth
| Last trade - 09.59am 07/08/2025 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable